A Randomized, Open-Label, Phase II Study of Sipuleucel-T with Concurrent vs Sequential Administration of Enzalutamide in Men with Metastatic Castrate Resistant Prostate Cancer

Diseases and Conditions Researched


What is the purpose of this trial?

This is a randomized, open-label study designed to assess the effects of sipuleucel-T when administered concurrently or sequentially with enzalutamide.

Participation Guidelines

Age: Any
Gender: Male

Click here for detailed participation information for this trial.

Sponsor: Dendreon Corporation
Last Updated:
Study HIC#: 1312013161